DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer.
<h4>Background</h4>Breast cancer in young women tends to have a natural history of aggressive disease for which rates of recurrence are higher than in breast cancers detected later in life. Little is known about the genetic pathways that underlie early-onset breast cancer. Here we report...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2009
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/80c15ad0ab1e4021a74355c082025b8e |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:80c15ad0ab1e4021a74355c082025b8e |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:80c15ad0ab1e4021a74355c082025b8e2021-11-25T05:37:39ZDEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer.1549-12771549-167610.1371/journal.pmed.1000068https://doaj.org/article/80c15ad0ab1e4021a74355c082025b8e2009-05-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19536326/pdf/?tool=EBIhttps://doaj.org/toc/1549-1277https://doaj.org/toc/1549-1676<h4>Background</h4>Breast cancer in young women tends to have a natural history of aggressive disease for which rates of recurrence are higher than in breast cancers detected later in life. Little is known about the genetic pathways that underlie early-onset breast cancer. Here we report the discovery of DEAR1 (ductal epithelium-associated RING Chromosome 1), a novel gene encoding a member of the TRIM (tripartite motif) subfamily of RING finger proteins, and provide evidence for its role as a dominant regulator of acinar morphogenesis in the mammary gland and as an independent predictor of local recurrence-free survival in early-onset breast cancer.<h4>Methods and findings</h4>Suppression subtractive hybridization identified DEAR1 as a novel gene mapping to a region of high-frequency loss of heterozygosity (LOH) in a number of histologically diverse human cancers within Chromosome 1p35.1. In the breast epithelium, DEAR1 expression is limited to the ductal and glandular epithelium and is down-regulated in transition to ductal carcinoma in situ (DCIS), an early histologic stage in breast tumorigenesis. DEAR1 missense mutations and homozygous deletion (HD) were discovered in breast cancer cell lines and tumor samples. Introduction of the DEAR1 wild type and not the missense mutant alleles to complement a mutation in a breast cancer cell line, derived from a 36-year-old female with invasive breast cancer, initiated acinar morphogenesis in three-dimensional (3D) basement membrane culture and restored tissue architecture reminiscent of normal acinar structures in the mammary gland in vivo. Stable knockdown of DEAR1 in immortalized human mammary epithelial cells (HMECs) recapitulated the growth in 3D culture of breast cancer cell lines containing mutated DEAR1, in that shDEAR1 clones demonstrated disruption of tissue architecture, loss of apical basal polarity, diffuse apoptosis, and failure of lumen formation. Furthermore, immunohistochemical staining of a tissue microarray from a cohort of 123 young female breast cancer patients with a 20-year follow-up indicated that in early-onset breast cancer, DEAR1 expression serves as an independent predictor of local recurrence-free survival and correlates significantly with strong family history of breast cancer and the triple-negative phenotype (ER(-), PR(-), HER-2(-)) of breast cancers with poor prognosis.<h4>Conclusions</h4>Our data provide compelling evidence for the genetic alteration and loss of expression of DEAR1 in breast cancer, for the functional role of DEAR1 in the dominant regulation of acinar morphogenesis in 3D culture, and for the potential utility of an immunohistochemical assay for DEAR1 expression as an independent prognostic marker for stratification of early-onset disease.Steven T LottNanyue ChenDawn S ChandlerQifeng YangLuo WangMarivonne RodriguezHongyan XieSeetharaman BalasenthilThomas A BuchholzAysegul A SahinKatrina ChaungBaili ZhangShodimu-Emmanu OlufemiJinyun ChenHenry AdamsVimla BandAdel K El-NaggarMarsha L FrazierKhandan KeyomarsiKelly K HuntSubrata SenBruce HafftyStephen M HewittRalf KraheAnn McNeill KillaryPublic Library of Science (PLoS)articleMedicineRENPLoS Medicine, Vol 6, Iss 5, p e1000068 (2009) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R |
| spellingShingle |
Medicine R Steven T Lott Nanyue Chen Dawn S Chandler Qifeng Yang Luo Wang Marivonne Rodriguez Hongyan Xie Seetharaman Balasenthil Thomas A Buchholz Aysegul A Sahin Katrina Chaung Baili Zhang Shodimu-Emmanu Olufemi Jinyun Chen Henry Adams Vimla Band Adel K El-Naggar Marsha L Frazier Khandan Keyomarsi Kelly K Hunt Subrata Sen Bruce Haffty Stephen M Hewitt Ralf Krahe Ann McNeill Killary DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. |
| description |
<h4>Background</h4>Breast cancer in young women tends to have a natural history of aggressive disease for which rates of recurrence are higher than in breast cancers detected later in life. Little is known about the genetic pathways that underlie early-onset breast cancer. Here we report the discovery of DEAR1 (ductal epithelium-associated RING Chromosome 1), a novel gene encoding a member of the TRIM (tripartite motif) subfamily of RING finger proteins, and provide evidence for its role as a dominant regulator of acinar morphogenesis in the mammary gland and as an independent predictor of local recurrence-free survival in early-onset breast cancer.<h4>Methods and findings</h4>Suppression subtractive hybridization identified DEAR1 as a novel gene mapping to a region of high-frequency loss of heterozygosity (LOH) in a number of histologically diverse human cancers within Chromosome 1p35.1. In the breast epithelium, DEAR1 expression is limited to the ductal and glandular epithelium and is down-regulated in transition to ductal carcinoma in situ (DCIS), an early histologic stage in breast tumorigenesis. DEAR1 missense mutations and homozygous deletion (HD) were discovered in breast cancer cell lines and tumor samples. Introduction of the DEAR1 wild type and not the missense mutant alleles to complement a mutation in a breast cancer cell line, derived from a 36-year-old female with invasive breast cancer, initiated acinar morphogenesis in three-dimensional (3D) basement membrane culture and restored tissue architecture reminiscent of normal acinar structures in the mammary gland in vivo. Stable knockdown of DEAR1 in immortalized human mammary epithelial cells (HMECs) recapitulated the growth in 3D culture of breast cancer cell lines containing mutated DEAR1, in that shDEAR1 clones demonstrated disruption of tissue architecture, loss of apical basal polarity, diffuse apoptosis, and failure of lumen formation. Furthermore, immunohistochemical staining of a tissue microarray from a cohort of 123 young female breast cancer patients with a 20-year follow-up indicated that in early-onset breast cancer, DEAR1 expression serves as an independent predictor of local recurrence-free survival and correlates significantly with strong family history of breast cancer and the triple-negative phenotype (ER(-), PR(-), HER-2(-)) of breast cancers with poor prognosis.<h4>Conclusions</h4>Our data provide compelling evidence for the genetic alteration and loss of expression of DEAR1 in breast cancer, for the functional role of DEAR1 in the dominant regulation of acinar morphogenesis in 3D culture, and for the potential utility of an immunohistochemical assay for DEAR1 expression as an independent prognostic marker for stratification of early-onset disease. |
| format |
article |
| author |
Steven T Lott Nanyue Chen Dawn S Chandler Qifeng Yang Luo Wang Marivonne Rodriguez Hongyan Xie Seetharaman Balasenthil Thomas A Buchholz Aysegul A Sahin Katrina Chaung Baili Zhang Shodimu-Emmanu Olufemi Jinyun Chen Henry Adams Vimla Band Adel K El-Naggar Marsha L Frazier Khandan Keyomarsi Kelly K Hunt Subrata Sen Bruce Haffty Stephen M Hewitt Ralf Krahe Ann McNeill Killary |
| author_facet |
Steven T Lott Nanyue Chen Dawn S Chandler Qifeng Yang Luo Wang Marivonne Rodriguez Hongyan Xie Seetharaman Balasenthil Thomas A Buchholz Aysegul A Sahin Katrina Chaung Baili Zhang Shodimu-Emmanu Olufemi Jinyun Chen Henry Adams Vimla Band Adel K El-Naggar Marsha L Frazier Khandan Keyomarsi Kelly K Hunt Subrata Sen Bruce Haffty Stephen M Hewitt Ralf Krahe Ann McNeill Killary |
| author_sort |
Steven T Lott |
| title |
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. |
| title_short |
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. |
| title_full |
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. |
| title_fullStr |
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. |
| title_full_unstemmed |
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. |
| title_sort |
dear1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2009 |
| url |
https://doaj.org/article/80c15ad0ab1e4021a74355c082025b8e |
| work_keys_str_mv |
AT steventlott dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT nanyuechen dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT dawnschandler dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT qifengyang dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT luowang dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT marivonnerodriguez dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT hongyanxie dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT seetharamanbalasenthil dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT thomasabuchholz dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT aysegulasahin dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT katrinachaung dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT bailizhang dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT shodimuemmanuolufemi dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT jinyunchen dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT henryadams dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT vimlaband dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT adelkelnaggar dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT marshalfrazier dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT khandankeyomarsi dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT kellykhunt dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT subratasen dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT brucehaffty dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT stephenmhewitt dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT ralfkrahe dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer AT annmcneillkillary dear1isadominantregulatorofacinarmorphogenesisandanindependentpredictoroflocalrecurrencefreesurvivalinearlyonsetbreastcancer |
| _version_ |
1718414587011792896 |